212 related articles for article (PubMed ID: 33585978)
1. APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses.
Watanabe A; Guaragna MS; Belangero VMS; Casimiro FMS; Pesquero JB; de Santis Feltran L; Palma LMP; Varela P; de Menezes Neves PDM; Lerario AM; de Souza ML; de Mello MP; de Brito Lutaif ACG; Ferrari CR; Sampson MG; Onuchic LF; Nogueira PCK
Pediatr Nephrol; 2021 Aug; 36(8):2327-2336. PubMed ID: 33585978
[TBL] [Abstract][Full Text] [Related]
2. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
[TBL] [Abstract][Full Text] [Related]
3. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG
Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333
[TBL] [Abstract][Full Text] [Related]
4. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
Zee J; McNulty MT; Hodgin JB; Zhdanova O; Hingorani S; Jefferson JA; Gibson KL; Trachtman H; Fornoni A; Dell KM; Reich HN; Bagnasco S; Greenbaum LA; Lafayette RA; Gipson DS; Brown E; Kretzler M; Appel G; Sambandam KK; Tuttle KR; Chen D; Atkinson MA; Hogan MC; Kaskel FJ; Meyers KE; O'Toole J; Srivastava T; Sethna CB; Hladunewich MA; Lin JJ; Nast CC; Derebail VK; Patel J; Vento S; Holzman LB; Athavale AM; Adler SG; Lemley KV; Lieske JC; Hogan JJ; Gadegbeku CA; Fervenza FC; Wang CS; Matar RB; Singer P; Kopp JB; Barisoni L; Sampson MG
Pediatr Nephrol; 2021 Sep; 36(9):2747-2757. PubMed ID: 33646395
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Genetic Risk Factors for Focal Segmental Glomerulosclerosis in Children: Results From the Chronic Kidney Disease in Children (CKiD) Cohort.
Durand A; Winkler CA; Vince N; Douillard V; Geffard E; Binns-Roemer E; Ng DK; Gourraud PA; Reidy K; Warady B; Furth S; Kopp JB; Kaskel FJ; Limou S
Am J Kidney Dis; 2023 Jun; 81(6):635-646.e1. PubMed ID: 36623684
[TBL] [Abstract][Full Text] [Related]
6. The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis.
Govender MA; Fabian J; Gottlich E; Levy C; Moonsamy G; Maher H; Winkler CA; Ramsay M
Commun Biol; 2019; 2():416. PubMed ID: 31754646
[TBL] [Abstract][Full Text] [Related]
7. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
[TBL] [Abstract][Full Text] [Related]
8. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
[TBL] [Abstract][Full Text] [Related]
9. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
Adeyemo A; Esezobor C; Solarin A; Abeyagunawardena A; Kari JA; El Desoky S; Greenbaum LA; Kamel M; Kallash M; Silva C; Young A; Hunley TE; de Jesus-Gonzalez N; Srivastava T; Gbadegesin R
Am J Kidney Dis; 2018 Mar; 71(3):399-406. PubMed ID: 29277510
[TBL] [Abstract][Full Text] [Related]
11. Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes.
Kallash M; Wang Y; Smith A; Trachtman H; Gbadegesin R; Nester C; Canetta P; Wang C; Hunley TE; Sperati CJ; Selewski D; Ayoub I; Srivastava T; Mottl AK; Kopp J; Gillespie B; Robinson B; Chen D; Steinke J; Twombley K; Reidy K; Mucha K; Greenbaum LA; Blazius B; Helmuth M; Yonatan P; Parekh RS; Hogan S; Royal V; D'Agati V; Chishti A; Falk R; Gharavi A; Holzman L; Klein J; Smoyer W; Kretzler M; Gipson D; Kidd JM;
Clin J Am Soc Nephrol; 2023 Mar; 18(3):344-355. PubMed ID: 36763813
[TBL] [Abstract][Full Text] [Related]
12. APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation.
Servais A; Gribouval O; Gaillard F; Antignac C
Nephrol Ther; 2019 Apr; 15 Suppl 1():S85-S89. PubMed ID: 30981401
[TBL] [Abstract][Full Text] [Related]
13. Early recurrence of focal segmental glomerulosclerosis in a kidney transplant recipient with
Acharya R; Upadhyay K
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37258049
[No Abstract] [Full Text] [Related]
14. Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis.
Gipson DS; Troost JP; Spino C; Attalla S; Tarnoff J; Massengill S; Lafayette R; Vega-Warner V; Adler S; Gipson P; Elliott M; Kaskel F; Fermin D; Moxey-Mims M; Fine RN; Brown EJ; Reidy K; Tuttle K; Gibson K; Lemley KV; Greenbaum LA; Atkinson MA; Hingorani S; Srivastava T; Sethna CB; Meyers K; Tran C; Dell KM; Wang CS; Yee JL; Sampson MG; Gbadegesin R; Lin JJ; Brady T; Rheault M; Trachtman H
JAMA Netw Open; 2022 Aug; 5(8):e2228701. PubMed ID: 36006643
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population.
Neves PD; Watanabe A; Watanabe EH; Narcizo AM; Nunes K; Lerario AM; Ferreira FM; Cavalcante LB; Wongboonsin J; Malheiros DM; Jorge LB; Sampson MG; Noronha IL; Onuchic LF
Kidney Int; 2024 Mar; 105(3):593-607. PubMed ID: 38143038
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.
Bruschi M; Catarsi P; Candiano G; Rastaldi MP; Musante L; Scolari F; Artero M; Carraro M; Carrea A; Caridi G; Zennaro C; Sanna-Cherchi S; Viola FB; Ferrario F; Perfumo F; Ghiggeri GM
Kidney Int; 2003 Feb; 63(2):686-95. PubMed ID: 12631135
[TBL] [Abstract][Full Text] [Related]
17. FSGS and COVID-19 in Non-African American Patients.
Medina E; Rueda C; Batlle D
Kidney360; 2023 May; 4(5):687-699. PubMed ID: 37229730
[TBL] [Abstract][Full Text] [Related]
18. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
19. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
[TBL] [Abstract][Full Text] [Related]
20. Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis?
Peng T; Li G; Zhong X; Wang L
Ren Fail; 2017 Nov; 39(1):500-504. PubMed ID: 28494221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
